Pulmonary circulation: clinical aspects

December 2007
Thorax;Dec2007 Supp, Vol. 62, pA83
Academic Journal
The article presents abstracts on medical topics which include the effect of infection on the rejection of single lung transplants by endothelium-dependent pulmonary vascular responses, the natriuretic response on acute ascent to high altitude and the comparison of six minute walk and hypoxic challenge in patients with pulmonary arterial hypertension.


Related Articles

  • Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing. Bonnet, Sébastien; Dubuis, Eric; Vandier, Christophe; Martin, Stéphanie; Marthan, Roger; Savineau, Jean-Pierre // Cardiovascular Research;Mar2002, Vol. 53 Issue 4, p1019 

    Objective: Chronic hypoxia (CH) induces selective pulmonary hypertension which is accompanied by structural and functional alterations in the pulmonary vasculature. Little information is available on the regression of CH-induced functional alterations of pulmonary wall. In the present...

  • Pulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis. Damy, Thibaud; Burgel, Pierre-R�gis; Pepin, Jean-Louis; Boelle, Pierre-Yves; Cracowski, Claire; Murris-Espin, Marl�ne; Nove-Josserand, Raphaele; Stremler, Nathalie; Simon, Tabassome; Adnot, Serge; Fauroux, Brigitte // Pulmonary Circulation;2012, Vol. 2 Issue 1, p75 

    Pulmonary hypertension (PH) may affect survival in cystic fibrosis (CF) and can be assessed on echocardiographic measurement of the pulmonary acceleration time (PAT). The study aimed at evaluating PAT as a tool to optimize timing of lung transplant in CF patients. Prospective multicenter...

  • Paradoxical Effect of Prostacyclin Infusion in a Patient with Primary Pulmonary Hypertension. Younger, Jared R.; Lui, Charles Y. // Angiology;May/Jun2004, Vol. 55 Issue 3, p341 

    Prostacyclin treatment successfully delays the need for lung transplantation in many patients with progressive primary pulmonary hypertension by vasodilating pulmonary arteries. However, the treatment of pulmonary hypertension with prostacyclin may cause a paradoxical increase in pulmonary...

  • Chronic Hypoxia- and Monocrotaline-Induced Elevation of Hypoxia-Inducible Factor-1α Levels and Pulmonary Hypertension. Yih-Loong Lai; Tai Chung Law // Journal of Biomedical Science;May/Jun2004, Vol. 11 Issue 3, p315 

    A close relationship exists between hypoxia-inducible factor (HIF)-1α and pulmonary hypertension. The present study was carried out to explore if there are temporal alterations in HIF-1α levels during prolonged hypoxia and after monocrotaline (MCT) treatment. First, young Wistar rats were...

  • Pulmonary hypertension and lung transplantation: Thorax publication activity review 2008e2010. Mydin, Helmy Haja; Fisher, Andrew J. // Thorax;Sep2012, Vol. 67 Issue 9, p828 

    A review is presented on articles published in Thorax between 2008 and 2010 relating to lung transplantation and pulmonary hypertension.

  • Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension. Wanstall, Janet C.; Gambino, Agatha; Jeffery, Trina K.; Cahill, Marian M.; Bellomo, Daniela; Hayward, Nicholas K.; Kay, Graham F. // Cardiovascular Research;Sep2002, Vol. 55 Issue 2, p361 

    Objective: To test the hypothesis that Vegf-B contributes to the pulmonary vascular remodelling, and the associated pulmonary hypertension, induced by exposure of mice to chronic hypoxia. Methods: Right ventricular systolic pressure, the ratio of right ventricle/[left...

  • Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. Brusselmans, Koen; Compernolle, Veerle; Tjwa, Marc; Wiesener, Michael S.; Maxwell, Patrick H.; Collen, Desire; Carmeliet, Peter // Journal of Clinical Investigation;5/15/2003, Vol. 111 Issue 10, p1519 

    Chronic hypoxia induces pulmonary vascular remodeling, leading to pulmonary hypertension, right ventricular hypertrophy, and heart failure. Heterozygous deficiency of hypoxia-inducible factor-1α (HIF-1α), which mediates the cellular response to hypoxia by increasing expression of genes...

  • Foreword.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 1, pIV 

    A foreword to the "Current Medical Literature: Pulmonary Hypertension" is presented.

  • Empowered Patient Online Toolkit.  // Advances in Pulmonary Hypertension;Summer2012, Vol. 11 Issue 2, p104 

    The article recommends the comprehensive Empowered Patient Toolkit for patients with pulmonary hypertension by Pulmonary Hypertension Association (PHA).


Read the Article


Sign out of this library

Other Topics